This content is restricted.
Brief
On February 14, 2025, the National Health Surveillance Agency (Anvisa) issued a consultation directed to review Product Framework Border. This move aims to improve the process of categorizing products that fall between different regulatory categories, such as medicaments, medical devices, and cosmetics, by collecting feedback from stakeholders involved in the process. The agency plans to use the collected information to define the problem, which is the initial step in the regulatory process.
Highlights content goes here...
This content is restricted.
RADA.AI
Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?
Suggested
